Ale (Maria) Vazquez-Gragg | VP, Head Global Patient Safety
Intarcia Therapeutics Inc

Ale (Maria) Vazquez-Gragg, VP, Head Global Patient Safety, Intarcia Therapeutics Inc

Dr. Vazquez-Gragg has extensive experience developing and driving safety-regulatory and medical organizations while combining pharmacovigilance, epidemiology and real-world data to quickly develop a lifecycle risk-benefit product profile and generate evidence to support regulatory initiates.


Day Two World Drug Safety Congress EU 2018 @ 14:05

RWE: Predictive Analytics to Impact Patient Safety

  • The use of new analytical tools applied to “big data” and gather real-time healthcare data are on the increase in the healthcare environment and have the potential to be of great value to make more informed and reliable strategic decisions earlier when it comes to protect patient safety.
  • Real-world evidence (RWE) offers great scientific and patient benefit as well as shortening phase III to accelerate the approval procedures.
  • This is mirrored by the need for pharmaceutical and biotech companies to quickly adapt their pharmacovigilance departments into cross-functional teams to confirm the expected benefit and value, often derived largely from controlled clinical studies. 

back to speakers